NYSE:PRAProAssurance Stock Price, Forecast & News

ProAssurance's stock was trading at $21.35 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, PRA shares have decreased by 36.1% and is now trading at $13.64. View which stocks have been most impacted by Coronavirus.

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ProAssurance in the last year. There are currently 2 sell ratings, 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for ProAssurance.

ProAssurance is scheduled to release its next quarterly earnings announcement on Wednesday, August 5th 2020. View our earnings forecast for ProAssurance.

ProAssurance Co. (NYSE:PRA) released its quarterly earnings results on Thursday, May, 7th. The insurance provider reported ($0.02) earnings per share for the quarter, missing the Zacks' consensus estimate of $0.05 by $0.07. The insurance provider earned $196.70 million during the quarter, compared to analyst estimates of $235.50 million. ProAssurance had a negative return on equity of 3.21% and a negative net margin of 5.67%. ProAssurance's revenue was down 26.8% compared to the same quarter last year. During the same quarter last year, the firm earned $0.08 earnings per share. View ProAssurance's earnings history.

ProAssurance announced a quarterly dividend on Thursday, May 7th. Investors of record on Thursday, June 11th will be paid a dividend of $0.05 per share on Wednesday, July 8th. This represents a $0.20 annualized dividend and a dividend yield of 1.47%. The ex-dividend date is Wednesday, June 10th. View ProAssurance's dividend history.

5 equities research analysts have issued 12-month target prices for ProAssurance's stock. Their forecasts range from $21.00 to $36.00. On average, they anticipate ProAssurance's share price to reach $27.00 in the next year. This suggests a possible upside of 97.9% from the stock's current price. View analysts' price targets for ProAssurance.

News coverage about PRA stock has trended somewhat negative recently, according to InfoTrie. The research firm ranks the sentiment of media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. ProAssurance earned a media sentiment score of -1.0 on InfoTrie's scale. They also assigned news stories about the insurance provider a news buzz of 4.0 out of 10, meaning that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the near term. View the latest news aboutProAssurance.

ProAssurance saw a increase in short interest in the month of May. As of May 15th, there was short interest totaling 955,500 shares, an increase of 10.4% from the April 30th total of 865,400 shares. Based on an average daily volume of 374,000 shares, the short-interest ratio is presently 2.6 days. Approximately 1.8% of the company's stock are sold short. View ProAssurance's Current Options Chain.

Some companies that are related to ProAssurance include Berkshire Hathaway (BRK.B), Progressive (PGR), Allstate (ALL), Travelers Companies (TRV), Markel (MKL), Arch Capital Group (ACGL), W. R. Berkley (WRB), Cincinnati Financial (CINF), Fidelity National Financial (FNF), Erie Indemnity (ERIE), Cna Financial (CNA), First American Financial (FAF), Old Republic International (ORI), Hanover Insurance Group (THG) and RLI (RLI). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other ProAssurance investors own include Gilead Sciences (GILD), AT&T (T), Walgreens Boots Alliance (WBA), Invesco (IVZ), KeyCorp (KEY), Marathon Petroleum (MPC), Uniti Group (UNIT), AbbVie (ABBV), Consolidated Edison (ED) and Energy Transfer LP Unit (ET).

ProAssurance trades on the New York Stock Exchange (NYSE) under the ticker symbol "PRA."

ProAssurance's stock is owned by many different institutional and retail investors. Top institutional investors include BlackRock Inc. (14.51%), State Street Corp (3.65%), Wells Fargo & Company MN (2.87%), Diamond Hill Capital Management Inc. (2.83%), Invesco Ltd. (2.31%) and Bank of New York Mellon Corp (1.47%). Company insiders that own ProAssurance stock include Frank Anthony Spinosa, John J Mcmahon, Jr and Magnus James Gorrie. View institutional ownership trends for ProAssurance.

PRA stock was sold by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., Victory Capital Management Inc., Morgan Stanley, Morgan Stanley, King Luther Capital Management Corp, UBS Group AG, Nuveen Asset Management LLC, and Bank of New York Mellon Corp. View insider buying and selling activity for ProAssurance.

PRA stock was acquired by a variety of institutional investors in the last quarter, including Wellington Management Group LLP, Diamond Hill Capital Management Inc., Invesco Ltd., State Street Corp, Geode Capital Management LLC, SG Americas Securities LLC, BlackRock Inc., and Bogle Investment Management L P DE. Company insiders that have bought ProAssurance stock in the last two years include Frank Anthony Spinosa, and Magnus James Gorrie. View insider buying and selling activity for ProAssurance.

Shares of PRA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of PRA stock can currently be purchased for approximately $13.64.

ProAssurance has a market capitalization of $734.43 million and generates $999.83 million in revenue each year. The insurance provider earns $1 million in net income (profit) each year or ($0.81) on an earnings per share basis. ProAssurance employs 991 workers across the globe.

The official website for ProAssurance is www.proassurance.com.

ProAssurance's mailing address is 100 Brookwood Place, Birmingham AL, 35209. The insurance provider can be reached via phone at 205-877-4400 or via email at [email protected]